
Home › Knowledge Hub › MDROs › CPE and Carbapenem Resistance in Aged Care
MDROs
By Lyndon Forrest, Managing Director · Clinically reviewed by Bridgette Mackie & Dianne Newey, Clinical Directors · May 2026 · 11 min read
CPE and Carbapenem Resistance in Aged Care
TL;DR —
Carbapenemase-producing Enterobacterales (CPE) represent the most critical antimicrobial resistance threat in aged care because carbapenems are last-resort antibiotics. In 2024, 8 of 10 CARAlert reports from aged care involved CPE. Management requires single-room isolation, enhanced cleaning, state/territory notification, and strict contact precautions. Prevention centres on antimicrobial stewardship and rigorous IPC practices.

What Is CPE and Why Is It Considered a Critical Threat?
Carbapenemase-producing Enterobacterales (CPE) are gut bacteria that produce enzymes (carbapenemases) capable of breaking down carbapenem antibiotics. Carbapenems — including meropenem, imipenem, and ertapenem — are considered last-resort antibiotics, used when other antibiotic classes have failed.
When bacteria develop resistance to carbapenems, there are very few treatment options remaining. CPE infections carry significantly higher mortality rates than infections caused by carbapenem-susceptible organisms, particularly in older and frailer populations.
The World Health Organisation (WHO) has classified carbapenem-resistant Enterobacterales as a Priority 1 (Critical) pathogen, the highest threat category. The Australian AURA Report (2025) noted that critical antibiotic resistance rose by 25.2% during 2024, with CPE contributing to this increase.
In Australia, CPE surveillance is coordinated through the CARAlert system, which monitors critical antimicrobial resistances nationally. CPE isolates in Australia are dominated by IMP-type (Imipenemase) and NDM-type (New-Delhi metallo-B-lactamase) carbapenemases (CARAlert, 2024).
For aged care facilities, CPE is arguably the most important MDRO to understand and manage. The consequences of CPE introduction and transmission within a facility can be severe, with limited treatment options, high morbidity, and significant regulatory implications.
How Common Is CPE in Australian Aged Care Facilities?
CPE remains relatively uncommon in Australian aged care compared with MRSA and VRE, but the trend is upward and concerning. In 2024, 10 CARAlert reports were received from aged care homes, of which 8 involved CPE (CARAlert, 2024).
Nationally, CPE disproportionately affects older Australians. In 2024, 73.9% of all CPE isolates (1,129 of 1,528 cases) were from people aged 50 and over. This age distribution reflects the higher rates of healthcare contact, hospitalisation, and antibiotic exposure in older populations.
| Year | CARAlert Reports from Aged Care | CPE Cases | Most Common CPE Types |
|---|---|---|---|
| 2024 | 10 | 8 of 10 were CPE | IMP-type, NDM-type |
While absolute numbers from aged care remain small, the increasing trend in CPE across all healthcare settings means that aged care facilities must be prepared. Residents frequently transfer between hospitals and aged care, and each transfer represents a potential introduction point for CPE.
The relatively low numbers should not breed complacency. International experience has shown that once CPE becomes established in a healthcare or aged care setting, it is extremely difficult to contain. Prevention and early detection are far more effective than reactive outbreak management.
What Are the Clinical Implications of CPE in Older People?
CPE infections in older people are associated with poor clinical outcomes. The limited treatment options mean that infections may progress more rapidly, hospital stays are prolonged, and mortality rates are significantly higher compared with infections caused by susceptible organisms.
Common CPE infections include urinary tract infections, bloodstream infections, pneumonia, and intra-abdominal infections. In aged care residents, urinary tract infections are the most frequent presentation, particularly in those with indwelling catheters.
The treatment of CPE infections requires specialist input from infectious diseases physicians or clinical microbiologists. Combination antibiotic therapy is often necessary, and the available agents — such as colistin, tigecycline, and newer beta-lactamase inhibitor combinations — carry significant side-effect profiles, particularly concerning in frail older adults.
As with other MDROs, the distinction between colonisation and infection is critical. CPE colonisation of the gut is often asymptomatic and does not require antibiotic treatment. However, colonised individuals serve as reservoirs for transmission and require appropriate infection prevention measures.
Goals-of-care conversations are particularly important when a frail older resident is diagnosed with CPE infection. The limited treatment options and potential side effects of available antibiotics must be discussed with the resident and family as part of person-centred care planning.
Need help implementing this in your facility? The IPS Hub gives your IPC Lead instant access to ready-made policies, procedures, and audit tools — updated monthly.
How Should Aged Care Facilities Respond to a CPE Case?
The response to a CPE case in aged care must be swift, systematic, and well-coordinated. CPE requires a more intensive response than most other MDROs due to the critical nature of carbapenem resistance. Facilities should have a CPE response plan prepared before a case occurs.
Place the resident in a single room with a dedicated bathroom where possible
Implement strict contact precautions — gloves and gown for all room entry
Notify the relevant state or territory public health authority as required
Inform the facility’s infection prevention committee or governance body
Commence enhanced environmental cleaning with hospital-grade disinfectant
Dedicate equipment to the CPE-positive resident
Review antibiotic prescribing for the resident and the facility
Communicate CPE status to all care providers, including GP and specialists
Educate staff on CPE-specific precautions and reinforce hand hygiene
Educate family members and visitors on hand hygiene and contact precautions
Document the management plan in the resident’s care plan
Staff allocation should be considered during the acute phase of management. Where possible, staff caring for the CPE-positive resident should not simultaneously care for other high-risk residents. This cohorting approach reduces the risk of cross-transmission.
The facility should maintain regular communication with the relevant public health authority and seek specialist advice from infectious diseases services. Many jurisdictions have CPE response protocols that facilities should follow.
What Are the CARAlert Reporting Requirements for CPE?
CARAlert is Australia’s national surveillance programme for critical antimicrobial resistances. It operates under the Australian Commission on Safety and Quality in Health Care (ACSQHC) and collects data on the most concerning resistance patterns nationally.
CPE is one of the key organisms monitored by CARAlert. Laboratories that identify CPE are expected to report to CARAlert, which tracks trends, identifies clusters, and informs national policy responses. In 2024, CARAlert data showed that CPE was dominated by IMP-type and NDM-type carbapenemases.
In addition to CARAlert reporting (which is primarily a laboratory-based system), aged care facilities must comply with their state or territory notification requirements. CPE is a notifiable condition in most Australian jurisdictions, and facilities must report confirmed cases to the relevant public health authority within the required timeframe.
Ensure laboratory reports are reviewed promptly for CPE results
Understand the notification requirements for your state or territory
Report CPE cases to the relevant public health authority within the required timeframe
Maintain records of notifications and follow-up actions
Participate in any public health authority-led response activities
Facilities should establish relationships with their local public health unit before a CPE case occurs. Knowing who to contact and what information is required will enable a faster and more effective response.
What Contact Precautions and Isolation Measures Are Needed for CPE?
CPE requires more intensive contact precautions than most other MDROs due to the critical nature of carbapenem resistance and the limited treatment options available. Single-room isolation with a dedicated bathroom is the recommended accommodation arrangement for CPE-positive residents.
Staff entering the room of a CPE-positive resident should don gloves and gown before entry and remove them before exiting. Hand hygiene must be performed before donning and after removing PPE. Equipment should be dedicated to the resident and not shared with others.
Enhanced environmental cleaning should be performed at least daily, with a focus on high-touch surfaces and bathroom areas. Hospital-grade disinfectant should be used in accordance with manufacturer instructions, ensuring adequate contact time.
When the resident leaves the room for essential activities (medical appointments, transfers), the receiving area should be notified of CPE status, and appropriate cleaning should be performed after the resident returns.
While these precautions are more restrictive than those for MRSA or VRE colonisation, facilities must still balance infection prevention with resident dignity. Activities, social engagement, and family visits should be facilitated to the extent possible within the constraints of necessary precautions.
The level of precautions should be reviewed regularly and adjusted based on the resident’s clinical status and specialist advice. For colonised residents who are clinically well, some relaxation of precautions may be appropriate after discussion with the public health authority and infectious diseases specialist.
How Does CPE Affect Antimicrobial Treatment Options?
CPE dramatically reduces available treatment options because carbapenems are typically reserved for the most serious, multidrug-resistant infections. When CPE causes infection, clinicians must rely on a small number of remaining agents, many of which have significant limitations.
| Agent | Activity Against CPE | Key Limitations |
|---|---|---|
| Colistin | Active against most CPE | Nephrotoxicity, narrow therapeutic window |
| Tigecycline | Variable activity | Not suitable for bloodstream infections |
| Ceftazidime-avibactam | Active against some CPE types | Not active against NDM-type CPE |
| Meropenem-vaborbactam | Active against KPC-type CPE | Limited availability in Australia |
The choice of antibiotic for CPE infection must be guided by individual susceptibility testing and specialist infectious diseases advice. Empirical treatment of suspected CPE infection is particularly challenging, as incorrect initial therapy is associated with worse outcomes.
This therapeutic limitation is precisely why CPE prevention is so critical. Every effort must be made to prevent CPE acquisition through antimicrobial stewardship, infection prevention measures, and effective surveillance.
What Can Aged Care Facilities Do to Prevent CPE?
CPE prevention in aged care requires the same foundational elements as all MDRO prevention — hand hygiene, standard precautions, environmental cleaning, and antimicrobial stewardship — but with heightened vigilance and intensity.
Maintain rigorous hand hygiene compliance across all staff groups
Implement robust antimicrobial stewardship programmes, focusing on reducing carbapenem and broad-spectrum antibiotic use
Ensure effective environmental cleaning with regular auditing
Ask about MDRO status when admitting residents from hospital
Develop a CPE response plan so the facility is prepared before a case occurs
Educate all staff on the significance of CPE and the importance of prevention
Participate in surveillance programmes (Aged Care NAPS, CARAlert awareness)
Establish relationships with the local public health unit and infectious diseases services
Antimicrobial stewardship is particularly important for CPE prevention. Carbapenem resistance is driven by antibiotic selection pressure, and reducing unnecessary broad-spectrum antibiotic use is the most effective way to prevent CPE emergence.
Facilities should view CPE prevention as a strategic priority, not an abstract risk. The consequences of CPE establishment within a facility — limited treatment options, potential fatalities, regulatory scrutiny, and reputational damage — warrant proactive investment in prevention.
Staff education on CPE should emphasise the critical nature of carbapenem resistance and the importance of every prevention measure. All staff — including nursing, personal care, cleaning, and allied health workers — should understand why CPE is classified as a Priority 1 threat and what their specific role is in preventing its introduction and spread.
Facilities should develop a CPE preparedness plan that includes a clear escalation pathway, pre-identified isolation rooms, a stockpile of appropriate PPE, pre-prepared communication templates for staff, families, and the public health authority, and a list of key contacts including infectious diseases specialists. Having these elements in place before a case occurs enables a rapid and coordinated response.
Regular simulation exercises — similar to outbreak drills — can help test the facility’s readiness to respond to a CPE case. These exercises reveal gaps in processes, equipment, and knowledge before a real case occurs, allowing facilities to address weaknesses proactively.
Compliance with the Strengthened Aged Care Quality Standards requires evidence that facilities have systems in place for managing critical infections such as CPE. Standard 5 Outcome 5.2 (Preventing and controlling infections in delivering clinical care services) and Actions 5.2.1(AMS system implemented) and 5.2.2 (implemented processes to minimise and manage infection) directly relate to CPE preparedness. Assessors may ask how the facility would respond to a CPE case, and documented preparedness plans demonstrate readiness.
Frequently Asked Questions
What is the difference between CPE and CRE?
CRE (carbapenem-resistant Enterobacterales) is a broader term for Enterobacterales that are resistant to carbapenems by any mechanism. CPE (carbapenemase-producing Enterobacterales) specifically refers to those that produce carbapenemase enzymes. CPE is considered higher risk because these enzymes can be transferred to other bacteria.
Should aged care facilities routinely screen for CPE on admission?
Routine CPE admission screening is not currently recommended for all aged care residents. However, facilities should ask about MDRO status for residents transferring from hospitals, particularly if they have been in intensive care units or overseas healthcare facilities.
Can CPE-positive residents attend communal activities?
This depends on the individual circumstances. Residents with CPE colonisation who are clinically well may be able to attend some activities with appropriate precautions, but this should be determined through risk assessment in consultation with infection prevention specialists and the public health authority.
Is CPE notifiable in all Australian states and territories?
CPE notification requirements vary by jurisdiction. Most Australian states and territories require notification of CPE to the relevant public health authority. Facilities should confirm their local notification obligations and establish reporting processes.
What happens if CPE spreads within an aged care facility?
CPE transmission within an aged care facility would likely trigger an outbreak response coordinated with the public health authority. This may include enhanced screening, increased environmental cleaning, additional staff cohorting, and potential restrictions on admissions or transfers.
References
Australian Commission on Safety and Quality in Health Care (ACSQHC). (2025). Infection Prevention and Control Guide for Aged Care. ACSQHC.
Australian Commission on Safety and Quality in Health Care (ACSQHC). (2025). AURA Surveillance Report 2025. ACSQHC.
CARAlert. (2024). CARAlert Annual Report 2024. ACSQHC.
Australian Government. (2024). Aged Care Act 2024. Federal Register of Legislation.
World Health Organisation (WHO). (2024). WHO Priority Pathogens List. WHO.
Copyright 2026 Bug Control Pty Ltd. All rights reserved.
In This Article
- What Is CPE and Why Is It Considered a Critical Threat?
- How Common Is CPE in Australian Aged Care Facilities?
- What Are the Clinical Implications of CPE in Older People?
- How Should Aged Care Facilities Respond to a CPE Case?
- What Are the CARAlert Reporting Requirements for CPE?
- What Contact Precautions and Isolation Measures Are Needed for CPE?
- How Does CPE Affect Antimicrobial Treatment Options?
- What Can Aged Care Facilities Do to Prevent CPE?
- Internal Links
- Frequently Asked Questions
- References
- Developer Section

About the Author
Lyndon Forrest is the Managing Director of Bug Control — Infection Prevention Services, with over 30 years’ experience supporting aged care facilities across Australia and New Zealand with infection prevention, antimicrobial stewardship, and accreditation readiness.
Clinically reviewed by Bridgette Mackie & Dianne Newey, Clinical Directors
Ready to Strengthen Your Facility’s Infection Prevention?
The IPS Hub provides aged care facilities across Australia and New Zealand with continuously updated IPC policies, AMS tools, outbreak management resources, and direct support from experienced IPC professionals.


